Juno Therapeutics, Inc., A Bristol-myers Squibb Company

This study tests whether a new treatment called BMS-986353 (a type of CAR T cell therapy) works better than current standard treatments for people with active systemic sclerosis, a disease that causes scarring in the skin and lungs. About 92 adults with lung involvement will be r…